160 related articles for article (PubMed ID: 2923577)
1. Homozygous familial hypercholesterolemia among French Canadians in Québec Province.
Moorjani S; Roy M; Gagné C; Davignon J; Brun D; Toussaint M; Lambert M; Campeau L; Blaichman S; Lupien P
Arteriosclerosis; 1989; 9(2):211-6. PubMed ID: 2923577
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic expression of familial hypercholesterolaemia in central and southern Tunisia.
Slimane MN; Pousse H; Maatoug F; Hammami M; Ben Farhat MH
Atherosclerosis; 1993 Dec; 104(1-2):153-8. PubMed ID: 8141839
[TBL] [Abstract][Full Text] [Related]
3. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
[TBL] [Abstract][Full Text] [Related]
4. Fine mapping of low-density lipoprotein receptor gene by genetic linkage on chromosome 19p13.1-p13.3 and study of the founder effect of four French Canadian low-density lipoprotein receptor gene mutations.
Couture P; Morissette J; Gaudet D; Vohl MC; Gagné C; Bergeron J; Després JP; Simard J
Atherosclerosis; 1999 Mar; 143(1):145-51. PubMed ID: 10208489
[TBL] [Abstract][Full Text] [Related]
5. Moderate phenotypic expression of familial hypercholesterolemia in Tunisia.
Jelassi A; Slimani A; Jguirim I; Najah M; Abid A; Boughamoura L; Mzid J; Fkih M; Maatouk F; Rouis M; Varret M; Slimane MN
Clin Chim Acta; 2010 May; 411(9-10):735-8. PubMed ID: 20144596
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians.
Bétard C; Kessling AM; Roy M; Chamberland A; Lussier-Cacan S; Davignon J
Hum Genet; 1992 Mar; 88(5):529-36. PubMed ID: 1348044
[TBL] [Abstract][Full Text] [Related]
7. Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.
Wang J; Huff E; Janecka L; Hegele RA
Hum Mutat; 2001 Oct; 18(4):359. PubMed ID: 11668627
[TBL] [Abstract][Full Text] [Related]
8. Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia.
Moorjani S; Roy M; Torres A; Bétard C; Gagné C; Lambert M; Brun D; Davignon J; Lupien P
Lancet; 1993 May; 341(8856):1303-6. PubMed ID: 8098448
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
Guo HC; Chapman MJ; Bruckert E; Farriaux JP; De Gennes JL
Atherosclerosis; 1991 Jan; 86(1):69-83. PubMed ID: 1829609
[TBL] [Abstract][Full Text] [Related]
10. A host of hypercholesterolaemic homozygotes in South Africa.
Seftel HC; Baker SG; Sandler MP; Forman MB; Joffe BI; Mendelsohn D; Jenkins T; Mieny CJ
Br Med J; 1980 Sep; 281(6241):633-6. PubMed ID: 7437743
[TBL] [Abstract][Full Text] [Related]
11. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
12. Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study.
Vuorio AF; Turtola H; Piilahti KM; Repo P; Kanninen T; Kontula K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3127-38. PubMed ID: 9409302
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
[TBL] [Abstract][Full Text] [Related]
14. Severe xanthomatosis in heterozygous familial hypercholesterolemia.
Aljenedil S; Ruel I; Watters K; Genest J
J Clin Lipidol; 2018; 12(4):872-877. PubMed ID: 29778561
[TBL] [Abstract][Full Text] [Related]
15. Geographic distribution of French-Canadian low-density lipoprotein receptor gene mutations in the Province of Quebec.
Vohl MC; Moorjani S; Roy M; Gaudet D; Torres AL; Minnich A; Gagné C; Tremblay G; Lambert M; Bergeron J; Couture P; Perron P; Blaichman S; Brun LD; Davignon J; Lupien PJ; Després JP
Clin Genet; 1997 Jul; 52(1):1-6. PubMed ID: 9272705
[TBL] [Abstract][Full Text] [Related]
16. Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia.
Hobbs HH; Brown MS; Russell DW; Davignon J; Goldstein JL
N Engl J Med; 1987 Sep; 317(12):734-7. PubMed ID: 3627182
[TBL] [Abstract][Full Text] [Related]
17. Familial hypercholesterolemia in French-Canadians: taking advantage of the presence of a "founder effect".
Davignon J; Roy M
Am J Cardiol; 1993 Sep; 72(10):6D-10D. PubMed ID: 8213499
[TBL] [Abstract][Full Text] [Related]
18. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia.
Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A
Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647
[TBL] [Abstract][Full Text] [Related]
19. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
Yu L; Qiu S; Genest J
Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the burden of familial hypercholesterolemia between two cohorts of French Canadians hospitalized 25 years apart for coronary heart disease.
Lauzière A; Brisson D; Tremblay G; Bédard S; Khoury E; Gaudet D
J Clin Lipidol; 2024; 18(1):e90-e96. PubMed ID: 38030518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
